glp-1 benefits beyond weight loss Loss: The Expanding of Medications GLP-1 receptor agonists for weight

PLoS ONE 16 , e0254129 (2021)

These peptides are tools that can accelerate results when the foundation is solid

Both DSIP and DSIP-CBBBP treatments increase serotonin levels significantly, suggesting their effectiveness in improving sleep effects, while CBBBP alone shows no significant impact on serum levels of melatonin, serotonin, dopamine, and glutamate

These dual targeting strategies of glucagon receptors offer exciting opportunities for treating obesity, diabetes, and even Alzheimers, where appetite and metabolic dysfunction play critical roles

Common sites: lower abdomen (2 inches from the navel), upper thigh, or upper outer arm